The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 19.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (9 analysts) rates it none, with a mean price target of $63.
Life360, Inc.
LIF · Nasdaq · USD · Market cap $3.5B · 547 employees
Life360, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-08-26
Screened 2026-08-26 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Life360, Inc. holds its Markdown at $43.42. Consolidating, no directional conviction, held for 4 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 4 days |
| Price at the screen | $43.42 |
| Valuation | 25.24 trailing · 24.33 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.09 |
Five Screens, Shown in Full
Does not pass. Accounts receivable
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 32.34% | Below 33% | Interest-bearing debt is just 32.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 59.91% | Below 49% | Money owed to the company is 59.9% of assets, above the 49% limit. | Fail |
| Revenue purity | 2.80% | Below 5% | Only 2.8% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-26 screen. The gold marker is the market price at the same screen. A 23.7% margin of safety to the base estimate.
Third-party analyst targets: 9 covering, consensus Strong Buy. The average target sits +40% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFamily tracker app finds fair value only
Every parent checking where their teenager's phone is at 11pm relies on the same location service. Life360 has built the platform that powers that habit across continents, delivering 38% revenue growth alongside 28% profit margins and 31% ROE. The business passes our ethical screen cleanly, yet our fair value sits exactly at the current share price, leaving no margin of safety and an opportunity rating of none.
Strong analyst support points to a $65 median target, but that optimism already sits in the 33 times forward earnings multiple. Without a clear moat, the valuation offers no cushion if growth moderates or rivals copy the freemium model.
High growth can flatten quickly in consumer apps, and an unknown competitive edge leaves the shares exposed to sudden shifts in user habits or platform fees. Analysis, not advice.
| Forward P/E | 24.3xcheap for a company growing this fast |
| Trailing P/E | 25.2xa premium valuation |
| EPS, trailing | 1.72 |
| EPS, forward | 1.78 |
| Revenue growth | +37.8%strong top-line growth |
| Profit margin | 25.7%healthy profit margins |
| Return on equity | 30.1%an exceptional return on shareholder capital |
| FCF yield | 2.11% |
| Debt to equity | 0.51moderate, manageable leverage |
| Current ratio | 5.60comfortably covers its short-term bills |
| Beta | 1.09moves a little more than the market |
| Short interest, float | 0.13% |
| 52-week range | 37.01 - 112.54 |
| Market cap | $3.5B |
| Employees | 547 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeLIF trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 18.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (9 analysts) rates it none, with a mean price target of $63.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (9 analysts) rates it none, with a mean price target of $63.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Apr2026 | Scott Peters | Democrat | buy | 50K–100K |
| 9 Apr2026 | Scott Peters | Democrat | buy | 250K–500K |
| 9 Apr2026 | Scott Peters | Democrat | buy | 50K–100K |
| 7 May2024 | Tommy Tuberville | Republican | buy | 1K–15K |
| 7 May2024 | Tommy Tuberville | Republican | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $43.28 | +5.8% | · | $1,058 | +5.8% |
| 2 months | $38.10 | +20.2% | · | $1,202 | +20.2% |
| 3 months | $41.21 | +11.1% | · | $1,111 | +11.1% |
| 6 months | $69.06 | -33.7% | · | $663 | -33.7% |
| 1 year | $62.50 | -26.8% | · | $733 | -26.8% |
| 2 years | $27.25 | +68.0% | · | $1,680 | +68.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LIF does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.